Objective: Lung cancer is still the leading cause of cancer-related death and the incidence continues to increase. The development of one-lung ventilation (OLV) techniques has pro-vided new surgical alternatives. The aim of this study was to investigate the demographic characteristics, anesthetic approaches, and factors that affected the prognosis of patients who underwent OLV in the treatment of lung cancer.Methods: With the approval of the ethics committee, the records of 114 patients who underwent a lobectomy or pneumonectomy with OLV for primary lung cancer were ret-rospectively reviewed. The age; sex; American Society of Anesthesiologists (ASA) score; comorbid diseases; operation type; complications; the quantity of fluid and blood given; the preoperative, peroperative, and postoperative hemogram and blood gas values; and the rate of postoperative transfer to the intensive care unit (ICU) were investigated.Results: The mean age of the patients was 56.35±12.42 years; 89 (78%) were male and 25 (22%) were female. It was observed that 75 (65.8%) of the patients were smokers. An ASA classification of I-II was seen in 59 patients (51.75%), and an ASA classification of III-IV was noted in 55 patients (48.25%). Hypertension, diabetes mellitus, and chronic obstructive pul-monary disease were the most commonly seen comorbid diseases. The number of patients who received ICU care was 29 (25.43%). Of the admitted patients, 19 (65.5%) were ASA III-IV and 10 (34.5%) were ASA I-II; 19 (65.5%) were intubated and 10 (34.5%) were extubated. In all, 97 (85%) cases were a lobectomy and 17 (15%) cases were pneumonectomy. Twenty (20.6%) of the lobectomy patients and 9 (52.9%) of the pneumonectomy patients were taken to the ICU. It was determined that the age, comorbidities, ASA score, and complications were greater in the ICU patients, as well as the duration of anesthesia and OLV. There were a total of 10 (8%) cases with prolonged air leak, bronchopleural fistula, hemorrhage, or pul-monary edema complications.Conclusion: It was concluded that a careful preoperative evaluation, surgical and anesthetic approach, and postoperative care are important to minimize the risk factors and improve the prognosis of thoracic surgery patients. These include bringing the lung function to the best possible state and assessing patient age, ASA score, comorbid diseases, operation type and anesthetic applications.
1. Campos JH. Progress in lung separation. Thorac Surg Clin 2005;15:71–83.
2. Banki F. Pulmonary assessment for general thoracic surgery. Surg Clin North Am 2010;90:969–84.
3. Dela Cruz CS, Tanoue LT, Matthay RA. Lung cancer: Epidemiology, etiology, and prevention. Clin Chest Med 2011;32:605-44.
4. Lynn T. Tanoue and Richard A. Matthay. Lung Cancer, Epidemiol-ogy and carcinogenesis. In: Shields TW, LoCicero J, Ponn R, editors. General Thoracic Surgery. 5 th ed. Philadelphia: Lippincott Williams & Wilkins; 2000. p. 1215–28.
5. Jaklitsch MT, Mery CM, Audisio RA. The use of surgery to treat lung cancer in elderly patients. Lancet Oncol 2003;4:463–71.
6. Birim Ö, Kappetein AP, Van Klaveren RJ, Bogers AJJC. Prognostic factors in non-small cell lung cancer surgery. EJSO 2006;32:12–23.
7. Akalın H. Yoğun bakım birimi infeksiyonları ve konsültasyonları. In: Eraksoy H, Yenen OŞ, editors. İnfeksiyon Hastalıkları ve Klinik Mikrobiyoloji. İstanbul: Nobel Tıp Kitabevi; 2000. p. 87–94.
8. Ceylan E, İtil O, Arı G, Ellidokuz H, Uçan ES, Akkoçlu A. Factors affecting mortality and morbidity in patients followed in medical in-tensive care unit. Turk Thorac J 2001;2:6–12.
9. Ursavaş A, Ege E, Yüksel EG. The evaluation of the factors affecting mortality in respiratory intensive care unit. J Med Surg Intensive Care Med 2006;6:43–8.
10. Günal H, Çalışır HC, Erol A, et al. Mortality in respiratory intensive care unit. Solunum Hastalıkları 2001;12:260–7.
11. Boussat S, El’rini T, Dubiez A, Depierre A, Barale F, Capellier G. Pre-dictive factors of death in primary lung cancer patients on admission to the intensive care unit. Intensive Care Medicine 2000;26:1811–6.
12. Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P. Smoking and lung cancer survival: the role of comorbidity and treatment. Chest 2004;125:27–37.
13. Sigel K, Bonomi M, Packer S, Wisnivesky J. Effect of age on sur-vival of clinical stage I non-small-cell lung cancer. Ann Surg Oncol 2009;16:1912–7.
14. Çakmur H, Erem MT, Koç M, Ertekin V, Karslıoğlu, Kırağı D. De-mographic evaluation of elderly cancer patients. Geriatri 2000;3:11–4.
15. Sağıroğlu G, Meydan B, İskenderoğlu İ, Çopuroğlu E, Küpeli M, Çağatay T, at al. Retrospective Analysis of Hundred Patients who had Undergone Lobectomy for Lung Cancer [Article in Turkish]. GKDA Derg 2013;19:16–22.
16. Radzikowska E, Głaz P, Roszkowski K. Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases. Ann Oncol 2002;13:1087–93.
17. Esener ZK. Torasik girişimlerde anestezi. In: Pediatrik Anestezi. Feryal Matbacılık Ltd Şti; p. 229–40.
18. Marcus M, Chen Yıng, Duffy S. Impact of comorbidity on lung can-cer mortality - a report from the Liverpool Lung Project. Oncol Lett 2015;9:1902–6.
19. Lee ES, Park SL, Kim YH, Bae CH, Moon HW, Chun MS, et al. Comparison of operative mortality and complications between bron-choplastic lobectomy and pneumonectomy in lung cancer patients. J Korean Med Sci 2007;22:43–7.
20. Kürkçüoğlu Cİ, Tokur M, Demircan S, Demirel CB, Özköse Z. Analysis of Peroperative Period During Anesthesia in Lung Cancer Patients [Article in Turkish]. Gazi Tıp Dergisi 2005;16:1:29–31.